C4B

C4B Protein

Score: 0.548 Price: $0.49 Medium Druggability Status: active
HYPOTHESES
1
PAPERS
13
KG EDGES
0
DEBATES
0

3D Protein Structure

🧬 C4B — PDB 4FXK Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

Druggability & Clinical Context

Druggability
Medium
Score: 0.50
Clinical Stage
Phase I
Target Class
Protein
Safety
0.50
Druggability Analysis
Drug Development0.00
Structural Tractability0.30
Target Class0.50
Safety Profile0.50
Key Metrics
PDB Structures:
0
Known Drugs:
0
Approved:
0
In Clinical Trials:
0
Therapeutic Areas:
neurodegeneration
Mechanism: Prioritized from 1 SciDEX hypotheses, including: Age-Dependent Complement C4b Upregulation Drives Synaptic Vulnerability in Hippocampal CA1 Neurons
Known Drugs:
No known drugs targeting this protein
Structural Data:

🧬 3D Protein Structure

🧬 C4B — PDB 4FXK Click to expand interactive 3D viewer

Experimental structure from RCSB PDB | Powered by Mol* | Rotate: click+drag | Zoom: scroll

Linked Hypotheses (1)

Age-Dependent Complement C4b Upregulation Drives Synaptic Vulnerability in Hippocampal CA1 Neurons0.470

Linked Experiments (0)

No linked experiments

Scoring Dimensions

Portfolio 0.00 (25%) Druggability 0.50 (20%) Evidence 0.89 (20%) Safety 0.50 (15%) Competitive 0.40 (10%) Connectivity 0.00 (10%) 0.548 composite

Knowledge Graph (20)

activates (1)

C4B C3

associated with (3)

C4B JUN
C4B TREM2
C4B neurodegeneration

biomarker for (2)

C4B ITGAM
C4B C1QA

component of (1)

C4B COMPLEMENT_CASCADE

expressed in (2)

C4B C4A
C4B GFAP

induced by (1)

C4B INTERFERON_GAMMA

interacts with (1)

C4B C1Q

mediates (1)

C4B SYNAPTIC_PRUNING

participates in (1)

C4B Classical complement cascade

pathology linked to (1)

C4B TAU

pathway partner (1)

C4B C1QA

regulated by (2)

C4B CD46
C4B CD55

regulates (1)

C4B GFAP

repressed by (1)

C4B PRC2

therapeutic target of (1)

C4B SUTIMLIMAB

Debate History (0)

No debates yet